Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 143 entries
Sorted by: Best Match Show Resources per page
Newborn Screening for 5q Spinal Muscular Atrophy: Comparisons between Real-Time PCR Methodologies and Cost Estimations for Future Implementation Programs.

International journal of neonatal screening

Romanelli Tavares VL, Monfardini F, Lourenço NCV, da Rocha KM, Weinmann K, Pavanello R, Zatz M.
PMID: 34449526
Int J Neonatal Screen. 2021 Aug 11;7(3). doi: 10.3390/ijns7030053.

Since the approval of modifying therapies for Spinal Muscular Atrophy (SMA), several protocols aiming to screen

Cite
Romanelli Tavares VL, Monfardini F, Lourenço NCV, et al. Newborn Screening for 5q Spinal Muscular Atrophy: Comparisons between Real-Time PCR Methodologies and Cost Estimations for Future Implementation Programs. Int J Neonatal Screen. 2021;7(3)doi: 10.3390/ijns7030053.
Romanelli Tavares, V. L., Monfardini, F., Lourenço, N. C. V., da Rocha, K. M., Weinmann, K., Pavanello, R., & Zatz, M. (2021). Newborn Screening for 5q Spinal Muscular Atrophy: Comparisons between Real-Time PCR Methodologies and Cost Estimations for Future Implementation Programs. International journal of neonatal screening, 7(3), . https://doi.org/10.3390/ijns7030053
Romanelli Tavares, Vanessa Luiza, et al. "Newborn Screening for 5q Spinal Muscular Atrophy: Comparisons between Real-Time PCR Methodologies and Cost Estimations for Future Implementation Programs." International journal of neonatal screening vol. 7,3 (2021). doi: https://doi.org/10.3390/ijns7030053
Romanelli Tavares VL, Monfardini F, Lourenço NCV, da Rocha KM, Weinmann K, Pavanello R, Zatz M. Newborn Screening for 5q Spinal Muscular Atrophy: Comparisons between Real-Time PCR Methodologies and Cost Estimations for Future Implementation Programs. Int J Neonatal Screen. 2021 Aug 11;7(3). doi: 10.3390/ijns7030053. PMID: 34449526; PMCID: PMC8396021.
Copy Download .nbib Format: NLM
Letter: Treatment Options for Hydrocephalus Following Foramen Magnum Decompression for Chiari I Malformation: A Multicenter Study.

Neurosurgery

Anania P, Fiaschi P, Balestrino A, Piatelli G, Pavanello M.
PMID: 32888304
Neurosurgery. 2020 Nov 16;87(6):E712-E713. doi: 10.1093/neuros/nyaa389.

No abstract available.

Cite
Anania P, Fiaschi P, Balestrino A, et al. Letter: Treatment Options for Hydrocephalus Following Foramen Magnum Decompression for Chiari I Malformation: A Multicenter Study. Neurosurgery. 2020;87(6):E712-E713doi: 10.1093/neuros/nyaa389.
Anania, P., Fiaschi, P., Balestrino, A., Piatelli, G., & Pavanello, M. (2020). Letter: Treatment Options for Hydrocephalus Following Foramen Magnum Decompression for Chiari I Malformation: A Multicenter Study. Neurosurgery, 87(6), E712-E713. https://doi.org/10.1093/neuros/nyaa389
Anania, Pasquale, et al. "Letter: Treatment Options for Hydrocephalus Following Foramen Magnum Decompression for Chiari I Malformation: A Multicenter Study." Neurosurgery vol. 87,6 (2020): E712-E713. doi: https://doi.org/10.1093/neuros/nyaa389
Anania P, Fiaschi P, Balestrino A, Piatelli G, Pavanello M. Letter: Treatment Options for Hydrocephalus Following Foramen Magnum Decompression for Chiari I Malformation: A Multicenter Study. Neurosurgery. 2020 Nov 16;87(6):E712-E713. doi: 10.1093/neuros/nyaa389. PMID: 32888304.
Copy Download .nbib Format: NLM
Efficient DFT Solver for Nanoscale Simulations and Beyond.

The journal of physical chemistry letters

Shao X, Mi W, Pavanello M.
PMID: 33887132
J Phys Chem Lett. 2021 May 06;12(17):4134-4139. doi: 10.1021/acs.jpclett.1c00716. Epub 2021 Apr 22.

We present the one-orbital ensemble self-consistent field (OE-SCF), an alternative orbital-free DFT solver that extends the applicability of DFT to beyond nanoscale system sizes, retaining the accuracy required to be predictive. OE-SCF treats the Pauli potential as an external...

Cite
Shao X, Mi W, Pavanello M. Efficient DFT Solver for Nanoscale Simulations and Beyond. J Phys Chem Lett. 2021;12(17):4134-4139doi: 10.1021/acs.jpclett.1c00716.
Shao, X., Mi, W., & Pavanello, M. (2021). Efficient DFT Solver for Nanoscale Simulations and Beyond. The journal of physical chemistry letters, 12(17), 4134-4139. https://doi.org/10.1021/acs.jpclett.1c00716
Shao, Xuecheng, et al. "Efficient DFT Solver for Nanoscale Simulations and Beyond." The journal of physical chemistry letters vol. 12,17 (2021): 4134-4139. doi: https://doi.org/10.1021/acs.jpclett.1c00716
Shao X, Mi W, Pavanello M. Efficient DFT Solver for Nanoscale Simulations and Beyond. J Phys Chem Lett. 2021 May 06;12(17):4134-4139. doi: 10.1021/acs.jpclett.1c00716. Epub 2021 Apr 22. PMID: 33887132.
Copy Download .nbib Format: NLM
Real-Life Use of Biosimilars in Pediatric Inflammatory Bowel Disease: A Nation-Wide Web Survey on Behalf of the SIGENP IBD Working Group.

Paediatric drugs

Dipasquale V, Martinelli M, Aloi M, Accomando S, Alvisi P, Arrigo S, Banzato C, Bramuzzo M, Cananzi M, Corpino M, Di Mari C, Di Nardo G, Dilillo A, Dodaro N, Felici E, Gatti S, Graziano F, Illiceto MT, Norsa L, Opramolla A, Pastore M, Pavanello PM, Romeo E, Scarallo L, Strisciuglio C, Zuin G, Romano C.
PMID: 34914084
Paediatr Drugs. 2021 Dec 16; doi: 10.1007/s40272-021-00486-8. Epub 2021 Dec 16.

OBJECTIVE: The aim was to assess the awareness and real-life use of biosimilars in inflammatory bowel disease (IBD) among the members of the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP).METHODS: An anonymous web survey involving all SIGENP...

Cite
Dipasquale V, Martinelli M, Aloi M, et al. Real-Life Use of Biosimilars in Pediatric Inflammatory Bowel Disease: A Nation-Wide Web Survey on Behalf of the SIGENP IBD Working Group. Paediatr Drugs. 2021;doi: 10.1007/s40272-021-00486-8.
Dipasquale, V., Martinelli, M., Aloi, M., Accomando, S., Alvisi, P., Arrigo, S., Banzato, C., Bramuzzo, M., Cananzi, M., Corpino, M., Di Mari, C., Di Nardo, G., Dilillo, A., Dodaro, N., Felici, E., Gatti, S., Graziano, F., Illiceto, M. T., Norsa, L., Opramolla, A., Pastore, M., Pavanello, P. M., Romeo, E., Scarallo, L., Strisciuglio, C., Zuin, G., & Romano, C. (2021). Real-Life Use of Biosimilars in Pediatric Inflammatory Bowel Disease: A Nation-Wide Web Survey on Behalf of the SIGENP IBD Working Group. Paediatric drugs, . https://doi.org/10.1007/s40272-021-00486-8
Dipasquale, Valeria, et al. "Real-Life Use of Biosimilars in Pediatric Inflammatory Bowel Disease: A Nation-Wide Web Survey on Behalf of the SIGENP IBD Working Group." Paediatric drugs vol. (2021). doi: https://doi.org/10.1007/s40272-021-00486-8
Dipasquale V, Martinelli M, Aloi M, Accomando S, Alvisi P, Arrigo S, Banzato C, Bramuzzo M, Cananzi M, Corpino M, Di Mari C, Di Nardo G, Dilillo A, Dodaro N, Felici E, Gatti S, Graziano F, Illiceto MT, Norsa L, Opramolla A, Pastore M, Pavanello PM, Romeo E, Scarallo L, Strisciuglio C, Zuin G, Romano C. Real-Life Use of Biosimilars in Pediatric Inflammatory Bowel Disease: A Nation-Wide Web Survey on Behalf of the SIGENP IBD Working Group. Paediatr Drugs. 2021 Dec 16; doi: 10.1007/s40272-021-00486-8. Epub 2021 Dec 16. PMID: 34914084.
Copy Download .nbib Format: NLM
RNF213 variant in a patient with Legius syndrome associated with moyamoya syndrome.

Molecular genetics & genomic medicine

Romanisio G, Chelleri C, Scala M, Piccolo G, Carlini B, Gatti L, Capra V, Zara F, Bersano A, Pavanello M, De Marco P, Diana MC.
PMID: 33939317
Mol Genet Genomic Med. 2021 Jun;9(6):e1669. doi: 10.1002/mgg3.1669. Epub 2021 May 03.

No abstract available.

Cite
Romanisio G, Chelleri C, Scala M, et al. RNF213 variant in a patient with Legius syndrome associated with moyamoya syndrome. Mol Genet Genomic Med. 2021;9(6):e1669doi: 10.1002/mgg3.1669.
Romanisio, G., Chelleri, C., Scala, M., Piccolo, G., Carlini, B., Gatti, L., Capra, V., Zara, F., Bersano, A., Pavanello, M., De Marco, P., & Diana, M. C. (2021). RNF213 variant in a patient with Legius syndrome associated with moyamoya syndrome. Molecular genetics & genomic medicine, 9(6), e1669. https://doi.org/10.1002/mgg3.1669
Romanisio, Giulia, et al. "RNF213 variant in a patient with Legius syndrome associated with moyamoya syndrome." Molecular genetics & genomic medicine vol. 9,6 (2021): e1669. doi: https://doi.org/10.1002/mgg3.1669
Romanisio G, Chelleri C, Scala M, Piccolo G, Carlini B, Gatti L, Capra V, Zara F, Bersano A, Pavanello M, De Marco P, Diana MC. RNF213 variant in a patient with Legius syndrome associated with moyamoya syndrome. Mol Genet Genomic Med. 2021 Jun;9(6):e1669. doi: 10.1002/mgg3.1669. Epub 2021 May 03. PMID: 33939317; PMCID: PMC8222830.
Copy Download .nbib Format: NLM
CRMP4-mediated fornix development involves Semaphorin-3E signaling pathway.

eLife

Boulan B, Ravanello C, Peyrel A, Bosc C, Delphin C, Appaix F, Denarier E, Kraut A, Jaquier-Sarlin M, Fournier A, Andrieux A, Gory-Fauré S, Deloulme JC.
PMID: 34860155
Elife. 2021 Dec 03;10. doi: 10.7554/eLife.70361.

Neurodevelopmental axonal pathfinding plays a central role in correct brain wiring and subsequent cognitive abilities. Within the growth cone, various intracellular effectors transduce axonal guidance signals by remodeling the cytoskeleton. Semaphorin-3E (Sema3E) is a guidance cue implicated in development...

Cite
Boulan B, Ravanello C, Peyrel A, et al. CRMP4-mediated fornix development involves Semaphorin-3E signaling pathway. Elife. 2021;10doi: 10.7554/eLife.70361.
Boulan, B., Ravanello, C., Peyrel, A., Bosc, C., Delphin, C., Appaix, F., Denarier, E., Kraut, A., Jaquier-Sarlin, M., Fournier, A., Andrieux, A., Gory-Fauré, S., & Deloulme, J. C. (2021). CRMP4-mediated fornix development involves Semaphorin-3E signaling pathway. eLife, 10. https://doi.org/10.7554/eLife.70361
Boulan, Benoît, et al. "CRMP4-mediated fornix development involves Semaphorin-3E signaling pathway." eLife vol. 10 (2021). doi: https://doi.org/10.7554/eLife.70361
Boulan B, Ravanello C, Peyrel A, Bosc C, Delphin C, Appaix F, Denarier E, Kraut A, Jaquier-Sarlin M, Fournier A, Andrieux A, Gory-Fauré S, Deloulme JC. CRMP4-mediated fornix development involves Semaphorin-3E signaling pathway. Elife. 2021 Dec 03;10. doi: 10.7554/eLife.70361. PMID: 34860155.
Copy Download .nbib Format: NLM
Publisher Correction: Integrating photonics with silicon nanoelectronics for the next generation of systems on a chip.

Nature

Atabaki AH, Moazeni S, Pavanello F, Gevorgyan H, Notaros J, Alloatti L, Wade MT, Sun C, Kruger SA, Meng H, Qubaisi KA, Wang I, Zhang B, Khilo A, Baiocco CV, Popović MA, Stojanović VM, Ram RJ.
PMID: 29930352
Nature. 2018 Aug;560(7716):E4. doi: 10.1038/s41586-018-0247-3.

In this Letter, owing to an error during the production process, the author affiliations were listed incorrectly. Affiliation number 5 (Colleges of Nanoscale Science and Engineering, State University of New York (SUNY)) was repeated, and affiliation numbers 6-8 were...

Cite
Atabaki AH, Moazeni S, Pavanello F, et al. Publisher Correction: Integrating photonics with silicon nanoelectronics for the next generation of systems on a chip. Nature. 2018;560(7716):E4doi: 10.1038/s41586-018-0247-3.
Atabaki, A. H., Moazeni, S., Pavanello, F., Gevorgyan, H., Notaros, J., Alloatti, L., Wade, M. T., Sun, C., Kruger, S. A., Meng, H., Qubaisi, K. A., Wang, I., Zhang, B., Khilo, A., Baiocco, C. V., Popović, M. A., Stojanović, V. M., & Ram, R. J. (2018). Publisher Correction: Integrating photonics with silicon nanoelectronics for the next generation of systems on a chip. Nature, 560(7716), E4. https://doi.org/10.1038/s41586-018-0247-3
Atabaki, Amir H, et al. "Publisher Correction: Integrating photonics with silicon nanoelectronics for the next generation of systems on a chip." Nature vol. 560,7716 (2018): E4. doi: https://doi.org/10.1038/s41586-018-0247-3
Atabaki AH, Moazeni S, Pavanello F, Gevorgyan H, Notaros J, Alloatti L, Wade MT, Sun C, Kruger SA, Meng H, Qubaisi KA, Wang I, Zhang B, Khilo A, Baiocco CV, Popović MA, Stojanović VM, Ram RJ. Publisher Correction: Integrating photonics with silicon nanoelectronics for the next generation of systems on a chip. Nature. 2018 Aug;560(7716):E4. doi: 10.1038/s41586-018-0247-3. PMID: 29930352.
Copy Download .nbib Format: NLM
A rare triad of morning glory disc anomaly, moyamoya vasculopathy, and transsphenoidal cephalocele: pathophysiological considerations and surgical management.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Pavanello M, Fiaschi P, Accogli A, Severino M, Tortora D, Piatelli G, Capra V.
PMID: 33825116
Neurol Sci. 2021 Dec;42(12):5433-5439. doi: 10.1007/s10072-021-05221-2. Epub 2021 Apr 06.

Morning glory disc anomaly is a congenital abnormality of the optic disc and peripapillary retina reported as an isolated condition or associated with various anomalies, including basal encephaloceles and moyamoya vasculopathy. However, the co-occurrence of these three entities is...

Cite
Pavanello M, Fiaschi P, Accogli A, et al. A rare triad of morning glory disc anomaly, moyamoya vasculopathy, and transsphenoidal cephalocele: pathophysiological considerations and surgical management. Neurol Sci. 2021;42(12):5433-5439doi: 10.1007/s10072-021-05221-2.
Pavanello, M., Fiaschi, P., Accogli, A., Severino, M., Tortora, D., Piatelli, G., & Capra, V. (2021). A rare triad of morning glory disc anomaly, moyamoya vasculopathy, and transsphenoidal cephalocele: pathophysiological considerations and surgical management. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 42(12), 5433-5439. https://doi.org/10.1007/s10072-021-05221-2
Pavanello, Marco, et al. "A rare triad of morning glory disc anomaly, moyamoya vasculopathy, and transsphenoidal cephalocele: pathophysiological considerations and surgical management." Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology vol. 42,12 (2021): 5433-5439. doi: https://doi.org/10.1007/s10072-021-05221-2
Pavanello M, Fiaschi P, Accogli A, Severino M, Tortora D, Piatelli G, Capra V. A rare triad of morning glory disc anomaly, moyamoya vasculopathy, and transsphenoidal cephalocele: pathophysiological considerations and surgical management. Neurol Sci. 2021 Dec;42(12):5433-5439. doi: 10.1007/s10072-021-05221-2. Epub 2021 Apr 06. PMID: 33825116.
Copy Download .nbib Format: NLM
Together we are stronger: COVID-19 for those of us with pre-existing conditions.

Breathe (Sheffield, England)

Pavanello S.
PMID: 33447281
Breathe (Sheff). 2020 Sep;16(3):200215. doi: 10.1183/20734735.0215-2020.

No abstract available.

Cite
Pavanello S. Together we are stronger: COVID-19 for those of us with pre-existing conditions. Breathe (Sheff). 2020;16(3):200215doi: 10.1183/20734735.0215-2020.
Pavanello, S. (2020). Together we are stronger: COVID-19 for those of us with pre-existing conditions. Breathe (Sheffield, England), 16(3), 200215. https://doi.org/10.1183/20734735.0215-2020
Pavanello, Stefano. "Together we are stronger: COVID-19 for those of us with pre-existing conditions." Breathe (Sheffield, England) vol. 16,3 (2020): 200215. doi: https://doi.org/10.1183/20734735.0215-2020
Pavanello S. Together we are stronger: COVID-19 for those of us with pre-existing conditions. Breathe (Sheff). 2020 Sep;16(3):200215. doi: 10.1183/20734735.0215-2020. PMID: 33447281; PMCID: PMC7792834.
Copy Download .nbib Format: NLM
Nonadiabatic couplings from a variational excited state method based on constrained DFT.

The Journal of chemical physics

Ramos P, Pavanello M.
PMID: 33412866
J Chem Phys. 2021 Jan 07;154(1):014110. doi: 10.1063/5.0028872.

Excited Costrained Density Functional Theory (XCDFT) [Ramos and Pavanello, J. Chem. Phys. 148, 144103 (2018)] is a variational excited state method that extends ground state DFT to the computation of low-lying excited states. It borrows much of the machinery...

Cite
Ramos P, Pavanello M. Nonadiabatic couplings from a variational excited state method based on constrained DFT. J Chem Phys. 2021;154(1):014110doi: 10.1063/5.0028872.
Ramos, P., & Pavanello, M. (2021). Nonadiabatic couplings from a variational excited state method based on constrained DFT. The Journal of chemical physics, 154(1), 014110. https://doi.org/10.1063/5.0028872
Ramos, Pablo, and Pavanello, Michele. "Nonadiabatic couplings from a variational excited state method based on constrained DFT." The Journal of chemical physics vol. 154,1 (2021): 014110. doi: https://doi.org/10.1063/5.0028872
Ramos P, Pavanello M. Nonadiabatic couplings from a variational excited state method based on constrained DFT. J Chem Phys. 2021 Jan 07;154(1):014110. doi: 10.1063/5.0028872. PMID: 33412866.
Copy Download .nbib Format: NLM
CRMP4-mediated fornix development involves Semaphorin-3E signaling pathway.

eLife

Boulan B, Ravanello C, Peyrel A, Bosc C, Delphin C, Appaix F, Denarier E, Kraut A, Jacquier-Sarlin M, Fournier A, Andrieux A, Gory-Fauré S, Deloulme JC.
PMID: 34860155
Elife. 2021 Dec 03;10. doi: 10.7554/eLife.70361.

Neurodevelopmental axonal pathfinding plays a central role in correct brain wiring and subsequent cognitive abilities. Within the growth cone, various intracellular effectors transduce axonal guidance signals by remodeling the cytoskeleton. Semaphorin-3E (Sema3E) is a guidance cue implicated in development...

Cite
Boulan B, Ravanello C, Peyrel A, et al. CRMP4-mediated fornix development involves Semaphorin-3E signaling pathway. Elife. 2021;10doi: 10.7554/eLife.70361.
Boulan, B., Ravanello, C., Peyrel, A., Bosc, C., Delphin, C., Appaix, F., Denarier, E., Kraut, A., Jacquier-Sarlin, M., Fournier, A., Andrieux, A., Gory-Fauré, S., & Deloulme, J. C. (2021). CRMP4-mediated fornix development involves Semaphorin-3E signaling pathway. eLife, 10. https://doi.org/10.7554/eLife.70361
Boulan, Benoît, et al. "CRMP4-mediated fornix development involves Semaphorin-3E signaling pathway." eLife vol. 10 (2021). doi: https://doi.org/10.7554/eLife.70361
Boulan B, Ravanello C, Peyrel A, Bosc C, Delphin C, Appaix F, Denarier E, Kraut A, Jacquier-Sarlin M, Fournier A, Andrieux A, Gory-Fauré S, Deloulme JC. CRMP4-mediated fornix development involves Semaphorin-3E signaling pathway. Elife. 2021 Dec 03;10. doi: 10.7554/eLife.70361. PMID: 34860155; PMCID: PMC8683083.
Copy Download .nbib Format: NLM
Ultrasonic Navigation for the Treatment of Medication-Related Jaw Osteonecrosis Involving the Inferior Alveolar Nerve: A Case Report and Protocol Review.

Methods and protocols

Pellegrino G, Pavanelli F, Ferri A, Lizio G, Parrulli R, Marchetti C.
PMID: 33096897
Methods Protoc. 2020 Oct 21;3(4). doi: 10.3390/mps3040070.

Dynamic navigation (DN) is a computer-guided technique employed in different surgical fields and recently adopted in dental implantology to improve the accuracy of dental implant insertion. Medication-related osteonecrosis of the jaws (MRONJ) often requires the surgical removal of the...

Cite
Pellegrino G, Pavanelli F, Ferri A, et al. Ultrasonic Navigation for the Treatment of Medication-Related Jaw Osteonecrosis Involving the Inferior Alveolar Nerve: A Case Report and Protocol Review. Methods Protoc. 2020;3(4)doi: 10.3390/mps3040070.
Pellegrino, G., Pavanelli, F., Ferri, A., Lizio, G., Parrulli, R., & Marchetti, C. (2020). Ultrasonic Navigation for the Treatment of Medication-Related Jaw Osteonecrosis Involving the Inferior Alveolar Nerve: A Case Report and Protocol Review. Methods and protocols, 3(4), . https://doi.org/10.3390/mps3040070
Pellegrino, Gerardo, et al. "Ultrasonic Navigation for the Treatment of Medication-Related Jaw Osteonecrosis Involving the Inferior Alveolar Nerve: A Case Report and Protocol Review." Methods and protocols vol. 3,4 (2020). doi: https://doi.org/10.3390/mps3040070
Pellegrino G, Pavanelli F, Ferri A, Lizio G, Parrulli R, Marchetti C. Ultrasonic Navigation for the Treatment of Medication-Related Jaw Osteonecrosis Involving the Inferior Alveolar Nerve: A Case Report and Protocol Review. Methods Protoc. 2020 Oct 21;3(4). doi: 10.3390/mps3040070. PMID: 33096897; PMCID: PMC7711829.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 143 entries